A simple score to estimate the likelihood of pseudoprogression vs. recurrence following stereotactic radiosurgery for brain metastases: The Bergen Criteria.

Bente Sandvei SkeiePer Øyvind EngerJonathan KniselyPaal-Henning PedersenJan Ingeman HeggdalGeir Egil EideGeir Olve Skeie

Published in: Neuro-oncology advances (2020)

Based on 5 characteristics at the time of SRS the Bergen Criteria could robustly differentiate between PP vs. TR following SRS. The score is user-friendly and provides a useful tool to guide the decision making whether to retreat or observe at appropriate follow-up intervals.

Keyphrases

brain metastases
small cell lung cancer
decision making
low cost